Understanding Causes Of Inferior Outcome In Adolescents And Young Adults With Acute Lymphoblastic Leukemia In A Real-World Setting

BACKGROUND: Adolescents and young adults (AYA: 15-39y) with acute lymphoblastic leukemia (ALL) have inferior survival when compared with children (1-14y). A comprehensive approach that examines the contribution of sociodemographics, clinical prognosticators, and treatment approach (pediatric vs. adult-inspired) in a real-world setting, is lacking.